Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Delek US
DK
$4.38B
| $136M | 0.18% |
3,339,428
-33,478
| -1% | -$1.2M |
|
|
MON
102
DELISTED
Monsanto Co
MON
| $135M | 0.18% |
1,154,415
+27,162
| +2% | +$3.27M |
|
103
OGE Energy
OGE
$9.42B
| $133M | 0.18% |
4,051,340
-19,602
| -0.5% | -$619K |
|
104
Cognizant
CTSH
$27.9B
| $132M | 0.18% |
1,638,312
+126,235
| +8% | +$9.98M |
|
105
Hyatt Hotels
H
$17B
| $130M | 0.17% |
1,709,133
+527,656
| +45% | +$41.4M |
|
106
Merck
MRK
$376B
| $129M | 0.17% |
2,488,869
+1,626,916
| +189% | +$87.9M |
|
107
Stanley Black & Decker
SWK
$15.1B
| $129M | 0.17% |
843,724
+269,037
| +47% | +$43.7M |
|
108
Western Digital
WDC
$166B
| $129M | 0.17% |
1,853,164
-477,225
| -20% | -$32.1M |
|
|
KLXI
109
DELISTED
KLX Inc.
KLXI
| $129M | 0.17% |
2,146,235
+1,809,789
| +538% | +$106M |
|
|
UMPQ
110
DELISTED
Umpqua Holdings Corp
UMPQ
| $129M | 0.17% |
6,006,151
+3,455,114
| +135% | +$75.5M |
|
111
Brunswick
BC
$5.24B
| $126M | 0.17% |
2,123,873
+811,545
| +62% | +$48M |
|
112
Packaging Corp of America
PKG
$22.5B
| $125M | 0.17% |
1,113,306
+482,533
| +76% | +$58.2M |
|
113
Union Pacific
UNP
$183B
| $125M | 0.17% |
932,130
+453,999
| +95% | +$61.1M |
|
|
COL
114
DELISTED
Rockwell Collins
COL
| $125M | 0.17% |
927,466
+334,198
| +56% | +$45.6M |
|
115
HCA Healthcare
HCA
$92.9B
| $125M | 0.17% |
1,283,659
+1,178,242
| +1,118% | +$114M |
|
116
PUT
iShares US Real Estate ETF
IYR
$4.62B
| $124M | 0.17% |
+1,645,700
| New | +$125M |
|
117
XPO
XPO
$23.2B
| $124M | 0.17% |
3,526,049
-996,357
| -22% | -$33.2M |
|
118
Texas Instruments
TXN
$241B
| $124M | 0.17% |
1,193,468
+587,659
| +97% | +$63.6M |
|
119
Thermo Fisher Scientific
TMO
$233B
| $124M | 0.17% |
599,623
+566,523
| +1,712% | +$119M |
|
120
US Bancorp
USB
$96.7B
| $123M | 0.16% |
2,425,766
+77,902
| +3% | +$4.26M |
|
|
AGN
121
DELISTED
Allergan plc
AGN
| $122M | 0.16% |
724,650
+72,895
| +11% | +$12.2M |
|
|
PE
122
DELISTED
PARSLEY ENERGY INC
PE
| $122M | 0.16% |
4,199,994
-700,717
| -14% | -$18.7M |
|
123
Biogen
BIIB
$32B
| $122M | 0.16% |
444,048
+389,965
| +721% | +$121M |
|
|
MFA
124
MFA Financial
MFA
$901M
| $121M | 0.16% |
4,016,349
+1,195,132
| +42% | +$35.5M |
|
125
Oneok
OKE
$58.8B
| $120M | 0.16% |
2,115,479
-689,157
| -25% | -$39.5M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.